Lataa...
Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare and disabling disorder of fibroblast growth factor 23 (FGF23) deficiency or resistance. The disorder is manifest by hyperphosphatemia, inappropriately increased tubular reabsorption of phosphate and 1,25-dihydroxy-Vitamin D, and ectopic...
Tallennettuna:
| Julkaisussa: | Front Endocrinol (Lausanne) |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225339/ https://ncbi.nlm.nih.gov/pubmed/32457699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.00293 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|